BridgeBio (BBIO), Amgen Partner in Advanced Solid Tumors Study

BridgeBio (BBIO), Amgen Partner in Advanced Solid Tumors Study
BridgeBio (BBIO) forges an alliance with Amgen to evaluate their respective cancer drugs for the treatment of advanced solid tumors with KRAS G12C mutations.

Continue reading

Leave a Reply

Your email address will not be published. Required fields are marked *